| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8771826 | The Journal of Urology | 2018 | 24 Pages |
Abstract
Whole gland high intensity focused ultrasound appears reasonably safe and effective to treat radiorecurrent prostate cancer. The rate of complications, which are potentially severe, was acceptable, especially considering the advanced, refractory nature of the disease and the limited treatment options.
Keywords
ADTFDAtransrectalPSAHRQOLHIFUEBRTProstate specific antigenMRIMagnetic resonance imagingandrogen deprivation therapySalvage therapyFood and Drug AdministrationProstate cancerhigh intensity focused ultrasoundhigh-intensity focusedadverse eventPostoperative complicationsNeoplasm recurrenceUltrasoundLocalProstatic neoplasmsexternal beam radiation therapyCaPhealth related quality of life
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Tonye A. Jones, Joseph Chin, David Mcleod, Jack Barkin, Allan Pantuck, Leonard S. Marks,